Table 1:
Drug class | Agent | Dosage | Cost per day, $† | |
---|---|---|---|---|
Without test strips | With test strips | |||
Metformin | Metformin | 500 mg four times daily | 0.50 | 1.24 |
Sulphonylureas | Glyburide | 5 mg twice daily | 0.73 | 1.64 |
Meglitinides | Repaglinide | 2 mg twice daily | 1.28 | 2.20 |
Thiazolidinediones | Pioglitazone | 30 mg once daily | 3.00 | 3.74 |
DPP-4 inhibitors | Sitagliptin | 100 mg once daily | 3.38 | 4.13 |
α-Glucosidase inhibitors | Acarbose | 100 mg three times daily | 1.76 | 2.50 |
Basal insulin | Insulin NPH | 0.75 U/kg daily | 1.95 | 3.60 |
Biphasic insulin | Regular human insulin or insulin NPH 30/70 | 1.50 U/kg daily | 3.81 | 5.45 |
Note: DPP-4 = dipeptidyl peptidase-4, NPH = neutral protamine hagedorn.
Patients using non-hypoglycemia-inducing oral glucose-lowering drugs were assumed to use 0.94 strips per day, those using insulin were assumed to use 2.08 test strips per day, and those using oral drugs in combination with sulphonylureas or meglitinides (both of which are associated with hypoglycemia) were assumed to use 1.16 test strips per day (based on data from the Ontario Drug Benefit Program).28
For all agents, costs are for the lowest-cost alternative.